PMID: 9178166May 1, 1997Paper

Transgenic animal models of familial amyotrophic lateral sclerosis

Journal of Neurology
M E Gurney

Abstract

Amyotrophic lateral sclerosis (ALS) occurs in both sporadic and familial forms, which have very similar clinical presentation and course. Approximately 20% of the familial cases of ALS are caused by mutation of the SODI gene encoding Cu, Zn superoxide dismutase (SOD). Over 30 different SODI gene mutations have been found in patients. Most are missense mutations that cause the substitution of one amino acid for another. The failure to find deletions in familial ALS suggests that the mutant protein is required for pathogenesis. Studies in transgenic mice indicate that familial ALS is caused by gain-of-function mutations in the SODI gene. These enhance formation of free radicals by the mutant enzyme. When expressed at high levels in transgenic mice, mutant human Cu,Zn SOD causes a clinical disease that resembles human ALS. Selective degeneration of motor neurones in the spinal cord and brainstem is accompanied by progressive motor impairment. Pathogenesis in the transgenic model of familial ALS is a sequential, two-step process in which damage mediated by free radicals accumulates to a threshold that triggers catastrophic motor neurone loss through glutamate-mediated, excitotoxic mechanisms. Evidence in support of this hypothesis ...Continue Reading

References

May 28, 1992·The New England Journal of Medicine·J D RothsteinR W Kuncl
Jul 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M B YimE R Stadtman
Apr 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·J P PhillipsA J Hilliker
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·C J EpsteinY Groner
Jul 1, 1995·Annals of Neurology·J D RothsteinR W Kuncl
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·M E RippsJ W Gordon
Aug 16, 1994·Proceedings of the National Academy of Sciences of the United States of America·D R BorcheltD W Cleveland
Mar 3, 1994·The New England Journal of Medicine·G BensimonV Meininger
Aug 12, 1993·Nature·J S BeckmanW H Koppenol
Nov 1, 1995·The Annals of Pharmacotherapy·D F WeltyJ D Rothstein

❮ Previous
Next ❯

Citations

Dec 25, 2008·Dysphagia·Teresa E LeverAlexander K Murashov
Jun 6, 2009·Dysphagia·Teresa E LeverAlexander K Murashov
Dec 31, 2010·Molecular Neurobiology·Bernardo Moreno-LópezDavid González-Forero
Jul 4, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·D Allan ButterfieldTanea Reed
Feb 14, 2002·Free Radical Biology & Medicine·James A RoeJoan Selverstone Valentine
Nov 7, 2002·Free Radical Biology & Medicine·Joan Selverstone Valentine
Mar 21, 2002·Epilepsy Research·Hannah R CockMatthew C Walker
Jul 8, 1999·Current Opinion in Neurobiology·R S Puranam, J O McNamara
Mar 26, 2003·Proceedings of the National Academy of Sciences of the United States of America·Joan Selverstone Valentine, P John Hart
Aug 28, 2012·The Journal of Clinical Investigation·Patrizia FanaraMarc K Hellerstein
Feb 7, 2012·Brain Research·Federica FulceriFrancesco Fornai
Oct 31, 2009·Neurobiology of Disease·Michela FerrucciFrancesco Fornai
Apr 4, 2009·Annals of Epidemiology·Kazushi OkamotoMasaki Nagai
Apr 21, 2005·Protein Science : a Publication of the Protein Society·Svetlana AntonyukS Samar Hasnain
Nov 28, 2009·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Pavle R AndjusGoran Bacić
Aug 10, 2002·Nutritional Neuroscience·D Allan ButterfieldVittorio Calabrese
Jan 27, 2012·Autoimmunity·Sharmilee GnanapavanGavin Giovannoni
Oct 30, 2004·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·Ling-Chun ChenNancy Lee
Mar 22, 2007·Muscle & Nerve·Clemens NeuschChristiane Schneider-Gold
Mar 16, 2013·Nature Reviews. Drug Discovery·Guillaume VaquerBruno Sepodes
Mar 20, 2003·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Soshanna Zittin Potter, Joan Selverstone Valentine
Oct 28, 1998·Physiological Reviews·M R Picciotto, K Wickman
Jul 17, 2012·Neuro-degenerative Diseases·Raquel ManzanoRosario Osta
Jun 22, 1999·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·R Brusa

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.